Related Experiment Video
Updated: May 25, 2026

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis
Published on: January 7, 2017
Minding the gap: Unlockingthe therapeutic potentialof aptamers and making up for lost time
Annalisa Di Ruscio1,2, Vittorio de Franciscis2,3
1Cancer Research Institute, Beth Israel Deaconess Medical Center, 330 Brookline Avenue Boston, Boston, MA 02215, USA.
Abstract:
Aptamers are RNAs that can bind proteins directly and modulate protein-protein interactions. Given their therapeutic potential, aptamers would be expected to capture the interest of both scientists and investors. However, concerns regarding safety, efficacy, and delivery have delayed aptamer development and dampened investor support. Herein, we discuss the major hurdles stalling the translational application of aptamers over recent years and focus on approaches to overcome current barriers and attract the scientific community and investors to the aptamer field.
More Related Videos
Related Concept Videos
Proofreading
Long-patch Base Excision Repair
Restarting Stalled Replication Forks

